NASDAQ:ELVN | Operating Income | Enliven Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$37.21M
2026-03-31-$27.82M
2025-12-31-$34.29M
2025-09-30-$25.1M
2025-06-30-$28.58M
2025-03-31-$31.69M
2024-12-31-$26.9M
2024-09-30-$27.07M
2024-06-30-$24.6M
2024-03-31-$25.99M
2023-12-31-$22.73M
2023-09-30-$24.25M
2023-06-30-$20.13M
2023-03-31-$16.42M
2022-12-31-$10.16M
2022-09-30-$10.93M
2022-06-30-$9.02M
2022-03-31-$8.68M
2021-12-31-$14.33M
2021-09-30-$13.66M
2021-06-30-$13.17M
2021-03-31-$10.28M
2020-12-31-$11.55M
2020-09-30-$12.49M
2020-06-30-$10.3M
2020-03-31-$7.35M
2019-12-31-$7.48M
2019-09-30-$6.88M
2019-06-30-$5.56M
2019-03-31-$4.19M

Annual Operating Income

DateOperating Income
2025-12-31-$119.66M
2024-12-31-$104.55M
2023-12-31-$83.53M
2022-12-31-$38.79M
2021-12-31-$51.44M
2020-12-31-$41.7M
2019-12-31-$24.12M